Richard M. Hoffman
Papers
1
Total Citations
64
H-Index
1
About
Richard M. Hoffman is a leading clinical epidemiologist and health services researcher whose work has fundamentally shaped our understanding of prostate cancer screening and treatment outcomes. His research centers on the comparative effectiveness and harms of cancer interventions, with a particular focus on prostate cancer diagnosis and management. In his landmark 2015 study, "The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples" (64 citations), Hoffman leveraged population-based cohort data to critically examine the real-world outcomes of robotic versus open prostatectomy, revealing that the widespread adoption of robotic surgery occurred without clear evidence of superiority in disease control or functional outcomes. This work exemplifies his broader contribution: using rigorous epidemiological methods to challenge clinical assumptions and illuminate the trade-offs inherent in cancer care. With a career spanning decades at the University of Iowa and the University of New Mexico, Hoffman has published extensively on PSA screening, cancer overdiagnosis, and shared decision-making. His research has been instrumental in informing clinical guidelines and helping patients and clinicians navigate the complex balance between potential benefits and harms of cancer interventions.
Research Focus
Key Achievements
Top Papers
- 1